Effects of n-3 PUFA on the CD4+ type 2 helper T-cell-mediated immune responses in Fat-1 mice

Molecular Nutrition and Food Research

Volumn 58, Issue 2, 2014, Pages 365-375

  Jang, Hyun Young ^a   Lim, Kyu ^b   Lee, Sang Myeong ^c   Park, Byung Hyun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Chungnam National University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Asthma; Fat 1; n 3 PUFA; Th2 cytokine

Indexed keywords

CADHERIN; CYTOKINE; FATH PROTEIN, MOUSE; IMMUNOGLOBULIN E; OMEGA 3 FATTY ACID; OVALBUMIN; TH2 CYTOKINE;

ANIMAL; ARTICLE; ASTHMA; BLOOD; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; FAT-1; GENETICS; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG LAVAGE; METABOLISM; MOUSE; N-3 PUFA; SPLEEN; TH2 CELL; TRANSGENIC MOUSE;

ASTHMA; FAT-1; N-3 PUFA; TH2 CYTOKINE;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE; CADHERINS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; IMMUNOGLOBULIN E; INFLAMMATION; LUNG; MICE; MICE, TRANSGENIC; OVALBUMIN; SPLEEN; TH2 CELLS;

EID: 84893360618     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300194     Document Type: Article

References (32)

1. Greenfeder, S., Umland, S. P., Cuss, F. M., Chapman, R. W. et al., Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir. Res. 2001, 2, 71-79.
2. Steinke, J. W., Borish, L., Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2001, 2, 66-70.
3. Bosnjak, B., Stelzmueller, B., Erb, K. J., Epstein, M. M., Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir. Res. 2011, 12, 114.
4. Eum, S. Y., Maghni, K., Tolloczko, B., Eidelman, D. H. et al., IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288, L576-L584.
5. Cosmi, L., Liotta, F., Maggi, E., Romagnani, S. et al., Th17 cells: new players in asthma pathogenesis. Allergy 2011, 66, 989-998.
6. Ruggiero, C., Lattanzio, F., Lauretani, F., Gasperini, B. et al., Omega-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis. Curr. Pharm. Des. 2009, 15, 4135-4148.
7. Mickleborough, T. D., Ionescu, A. A., Rundell, K. W., Omega-3 fatty acids and airway hyperresponsiveness in asthma. J. Altern. Complement. Med. 2004, 10, 1067-1075.
8. Bilal, S., Haworth, O., Wu, L., Weylandt, K. H. et al., Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses. Biochim. Biophys. Acta 2011, 1812, 1164-1169.
9. Levy, B. D., Vachier, I., Serhan, C. N., Resolution of inflammation in asthma. Clin. Chest Med. 2012, 33, 559-570.
10. Kim, W., Khan, N. A., McMurray, D. N., Prior, I. A. et al., Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog. Lipid Res. 2010, 49, 250-261.
11. Switzer, K. C., McMurray, D. N., Chapkin, R. S., Effects of dietary n-3 polyunsaturated fatty acids on T-cell membrane composition and function. Lipids 2004, 39, 1163-1170.
12. Zhang, P., Kim, W., Zhou, L., Wang, N. et al., Dietary fish oil inhibits antigen-specific murine Th1 cell development by suppression of clonal expansion. J. Nutr. 2006, 136, 2391-2398.
13. Turk, H. F., Chapkin, R. S., Membrane lipid raft organization is uniquely modified by n-3 polyunsaturated fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2012, 88, 43-47.
14. Yog, R., Barhoumi, R., McMurray, D. N., Chapkin, R. S., n-3 polyunsaturated fatty acids suppress mitochondrial translocation to the immunologic synapse and modulate calcium signaling in T cells. J. Immunol. 2010, 184, 5865-5873.
15. Kang, J. X., Wang, J., Wu, L., Kang, Z. B., Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427, 504.
16. Kim, W., Fan, Y. Y., Barhoumi, R., Smith, R. et al., n-3 polyunsaturated fatty acids suppress the localization and activation of signaling proteins at the immunological synapse in murine CD4+ T cells by affecting lipid raft formation. J. Immunol. 2008, 181, 6236-6243.
17. Zhang, P., Smith, R., Chapkin, R. S., McMurray, D. N., Dietary (n-3) polyunsaturated fatty acids modulate murine Th1/Th2 balance toward the Th2 pole by suppression of Th1 development. J. Nutr. 2005, 135, 1745-1751.
18. Weil, R., Israel, A., Deciphering the pathway from the TCR to NF-κB. Cell Death Differ. 2006, 13, 826-833.
19. Ghosh, S., May, M. J., Kopp, E. B., NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16, 225-260.
20. Aoshiba, K., Nagai, A., Differences in airway remodeling between asthma and chronic obstructive pulmonary disease. Clin. Rev. Allergy Immunol. 2004, 27, 35-43.
21. Tournoy, K. G., Provoost, S., Van Hove, C., Joos, G., The role of immune tolerance in asthma pathogenesis. Curr. Allergy Asthma Rep. 2006, 6, 437-443.
22. Cook, M. L., Bochner, B. S., Update on biological therapeutics for asthma. World Allergy Organ. J. 2010, 3, 188-194.
23. Reisman, J., Schachter, H. M., Dales, R. E., Tran, K. et al., Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review. BMC Complement. Altern. Med. 2006, 6, 26.
24. Chatila, T. A., Li, N., Garcia-Lloret, M., Kim, H. J. et al., T-cell effector pathways in allergic diseases: transcriptional mechanisms and therapeutic targets. J. Allergy Clin. Immunol. 2008, 121, 812-823.
25. Attakpa, E., Hichami, A., Simonin, A. M., Sanson, E. G. et al., Docosahexaenoic acid modulates the expression of T-bet and GATA-3 transcription factors, independently of PPARalpha, through suppression of MAP kinase activation. Biochimie 2009, 91, 1359-1365.
26. Wong, C. K., Lun, S. W., Ko, F. W., Wong, P. T. et al., Activation of peripheral Th17 lymphocytes in patients with asthma. Immunol. Invest. 2009, 38, 652-664.
27. Kong, W., Yen, J. H., Ganea, D., Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2011, 25, 872-882.
28. Monk, J. M., Jia, Q., Callaway, E., Weeks, B. et al., Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice. J. Nutr. 2012, 142, 117-124.
29. Cvetanovich, G. L., Hafler, D. A., Human regulatory T cells in autoimmune diseases. Curr. Opin. Immunol. 2010, 22, 753-760.
30. Ray, A., Khare, A., Krishnamoorthy, N., Qi, Z. et al., Regulatory T cells in many flavors control asthma. Mucosal Immunol. 2010, 3, 216-229.
31. Iwami, D., Nonomura, K., Shirasugi, N., Niimi, M., Immunomodulatory effects of eicosapentaenoic acid through induction of regulatory T cells. Int. Immunopharmacol. 2011, 11, 384-389.
32. Weise, C., Heunemann, C., Loddenkemper, C., Herz, U. et al., Dietary docosahexaenoic acid in combination with arachidonic acid ameliorates allergen-induced dermatitis in mice. Pediatr. Allergy Immunol. 2011, 22, 497-504.